In Long-Term Exploratory Analysis, TAK-003 Prevented 84% of Hospitalizations and 61% of Symptomatic Dengue Illness Overall, with No Identified Important Safety Risks Results Through 4.5 Years Conclude the Evaluation of… Read More
Introducing the Canada Gairdner Momentum Award! This award annually recognizes 2 mid-career investigators (typically 10-15 years past their first independent research appointment) working in Canada who in their last 6 active… Read More
Produces highly pure d9-dominant THCV, a non-intoxicating cannabinoid Bolsters Company’s commercial portfolio, which also includes CBDV, CBC and CBT THCV has been researched for a variety of potential benefits VANCOUVER,… Read More
For UBC researchers and scientists focusing on innovations that will advance the future of our world Lab2Launch supports UBC researchers and scientists who plan to build, or are building, a deep… Read More
New scientific advisors bring expertise in cell therapy development, surgery & transplantation, liver disease, diabetes, and biomaterials VANCOUVER, BC — Aspect Biosystems, a biotechnology company pioneering the development of bioengineered… Read More
